Anaphylaxis: Assessment of a Disease-Based Military Medical Standard
Source: Military Medicine, Volume 176, Number 8, August 2011 , pp. 889-895(7)
Although widespread, the use of disease-based employment medical standards is poorly understood or researched. A probabilistic model and threshold value are developed and applied to a military (Canadian Forces [CF]) medical standard for anaphylaxis. Frequency estimates of prevalence, occurrence, and impairing reactions are determined from the literature for military applicants and from medical chart review of military members identified by prescriptions for self-administered epinephrine. The prevalence of prescriptions is 1.13% (CI 1.05, 1.22) and 0.86% (CI 0.72, 1.00) in the CF Regular Force and applicant populations, respectively. The proposed model predicts the annual risk of an impairing allergic reaction in the CF population ranges from 0.1% to 0.16%/year, well below the proposed threshold of 0.5%. The majority of this risk arises from new cases and not recurrences. Requirement for care increases with recurrence. This model allows a useful method of disease-based medical standard review.
Document Type: Research Article
Affiliations: 1: Canadian Forces Environmental Medicine Establishment, 1133 Sheppard Avenue West, Toronto, Ontario M3K 2B3. 2: Outcomes Research—Pharmacy Policy and Standards, Canadian Forces Directorate of Medical Policy, 1745 Alta Vista Drive-Rm 214, Ottawa, Ontario K1A 0K6.
Publication date: 2011-08-01
- Military Medicine is the Association's official monthly journal. The objective of the Journal is to promote awareness of Federal medicine by providing a forum for responsible discussion of common ideas and problems relevant to Federal healthcare. Its mission is: To increase healthcare education by providing scientific and other information to its readers; to facilitate communication; and to offer a prestige publication for members' writings.
Military Medicine's 5-year Impact Factor: 1.061
- Editorial Board
- Information for Authors
- Submit a Paper
- Subscribe to this Title
- Membership Information
- Information for Advertisers
- Terms & Conditions
- Reviewer Information
- ingentaconnect is not responsible for the content or availability of external websites